Ciprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response: Study Protocol for a Cluster-Randomized Trial
dc.contributor.author | Coldiron, M | |
dc.contributor.author | Alcoba, G | |
dc.contributor.author | Ciglenecki, I | |
dc.contributor.author | Hitchings, M | |
dc.contributor.author | Djibo, A | |
dc.contributor.author | Page, A | |
dc.contributor.author | Langendorf, C | |
dc.contributor.author | Grais, R | |
dc.date.accessioned | 2017-07-06T18:06:13Z | |
dc.date.available | 2017-07-06T18:06:13Z | |
dc.date.issued | 2017-06-24 | |
dc.date.submitted | 2017-07-06 | |
dc.identifier.citation | Ciprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response: Study Protocol for a Cluster-Randomized Trial. 2017, 18 (1):294 Trials | en |
dc.identifier.issn | 1745-6215 | |
dc.identifier.pmid | 28646924 | |
dc.identifier.doi | 10.1186/s13063-017-2028-y | |
dc.identifier.uri | http://hdl.handle.net/10144/618956 | |
dc.description.abstract | Epidemics of meningococcal meningitis are common in the "African meningitis belt." Current response strategies include reactive vaccination campaigns, which are often organized too late to have maximal impact. A novel strain of Neisseria meningitidis serogroup C has been circulating in recent years, and vaccine supplies are limited. An evaluation of chemoprophylaxis with single-dose ciprofloxacin for household contacts of meningitis cases has therefore been recommended. | |
dc.language.iso | en | en |
dc.publisher | BioMed Central | en |
dc.rights | Archived with thanks to Trials | en |
dc.title | Ciprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response: Study Protocol for a Cluster-Randomized Trial | en |
dc.identifier.journal | Trials | en |
refterms.dateFOA | 2019-03-04T13:29:33Z | |
html.description.abstract | Epidemics of meningococcal meningitis are common in the "African meningitis belt." Current response strategies include reactive vaccination campaigns, which are often organized too late to have maximal impact. A novel strain of Neisseria meningitidis serogroup C has been circulating in recent years, and vaccine supplies are limited. An evaluation of chemoprophylaxis with single-dose ciprofloxacin for household contacts of meningitis cases has therefore been recommended. |